Co-morbidity and disease status at the time of transplant predict outcome following allogeneic haematopoietic stem cell transplantation (HSCT) for poor risk myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML)

W Ingram, Z Y Lim, M Kenyon, S Devereux, A Pagliuca, A Y L Ho, M Ghulam

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)3108
Number of pages1
JournalBlood
Volume108
Issue number11
Publication statusPublished - 2006
Event48th Annual Meeting of the American-Society-of-Hematology - Orlando, FL
Duration: 9 Dec 000612 Dec 0006

Cite this